Orchestra BioMed Holdings Inc
OBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$364.07M
Close$
$-5.59
194.2% downside
Current Fair Value
194.2% downsideOvervalued by 194.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $364.07 Million |
|---|---|
| Enterprise Value | $365.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.11 |
| Beta | 0.53 |
| Outstanding Shares | 63,812,098 |
Return
| Return on Equity | -201.51% |
|---|---|
| Return on Assets | -51.24% |
| Return on Invested Capital | -58.10% |
Valuation & Multiples
| P/E Ratio | -6.14 |
|---|---|
| PEG | -27.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 11.43 |
| Enterprise Value to EBIT | -6.15 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$254,429
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
$128,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.3967▲ 239.67% |
|---|---|
| Total Calls | 12,100▼ 20.92% |
| Total Puts | 29,000▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 43.95%▲ 7.12% |
|---|---|
| Total Invested | $120.95M▲ 23.18% |
| Investors Holding | 81▲ 15.00% |
ESG Score
No data
About Orchestra BioMed Holdings Inc
4 employees